NASDAQ: NVNO - enVVeno Medical Corporation

六个月盈利: -36.36%
部门: Healthcare

促销时间表 enVVeno Medical Corporation

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021.

更多详情
enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

EBITDA -0.0066
EV/EBITDA -1.24
IPO date 2018-05-31
ISIN US29415J1060
Industry Health Care Equipment & Supplies
P/BV 8.76
P/S 277.45
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 3.1E-5
Сайт https://www.envveno.com
Цена ао 5.46
Число акций ао 0.0123 млрд
每日价格变化: +1.26% (3.18)
每周价格变化: -0.6173% (3.24)
每月价格变化: -37.6% (5.16)
3个月内价格变化: -35.34% (4.98)
六个月内的价格变化: -36.36% (5.06)
每年价格变化: -33.95% (4.875)
3年内价格变化: -67.64% (9.95)
5年内价格变化: +235.42% (0.96)
年初以来价格变化: -39.02% (5.28)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 1.32 9
P/E 0 0
EV/EBITDA -2.39 0
全部的: 3.63

效率

姓名 意义 年级
ROA, % -48.35 0
ROE, % -50.9 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0568 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -96.06 0
盈利能力 Ebitda, % 274.12 10
盈利能力 EPS, % -84.2 0
全部的: 6
更多详情

机构 体积 分享, %
Nantahala Capital Management, LLC 1412638 10.61
Perceptive Advisors LLC 623315 4.68
Kingdon Capital Management LLC 619180 4.65
Armistice Capital, LLC 436000 3.27
Altium Capital Management, LP 344471 2.59
Vanguard Group Inc 336405 2.53
Rosalind Advisors, Inc. 312091 2.34
UBS OConnor LLC 236308 1.77
Velan Capital Investment Management LP 172235 1.29
Geode Capital Management, LLC 122116 0.92

ETF 分享, % 本年盈利能力, % 股息, %
iShares Micro-Cap ETF 0.01259 29.340359461748 1.54048



导师 职称 支付 出生年份
Mr. Robert A. Berman CEO & Director 1.02M 1963 (61 年)
Mr. Craig Thomas Glynn CFO, Treasurer & Secretary 313.69k 1961 (63 年)
Dr. Hamed Alavi Ph.D. Senior VP & Chief Technology Officer 384.39k
Dr. Marc H. Glickman M.D. Senior VP & Chief Medical Officer 491.59k 1949 (75 年)
Mr. Warren Hancock Co-founder N/A
Dr. Benedict Broennimann M.D. Chief Medical Officer of Outside of United States 240k 1957 (67 年)
Mr. Andrew Cormack Chief Commercial Officer N/A
Ms. Sandy Prietto Vice President of Marketing

地址: United States, Irvine. CA, 70 Doppler - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.envveno.com